Shenzhen Haibin Pharmaceutical Co. Ltd
Shenzhen Haibin Pharmaceutical Co. Ltd., commonly referred to as Haibin Pharma, is a prominent player in the pharmaceutical industry, headquartered in Shenzhen, China. Established in 2001, the company has rapidly expanded its operations across major regions in Asia and beyond, focusing on the development and manufacturing of high-quality pharmaceutical products. Specialising in active pharmaceutical ingredients (APIs) and finished dosage forms, Haibin Pharma is recognised for its commitment to innovation and quality. The company’s core offerings include a diverse range of generic medications and specialty pharmaceuticals, which are distinguished by their efficacy and safety profiles. With a strong market position, Haibin Pharma has achieved significant milestones, including various certifications and partnerships that underscore its reputation for excellence in the pharmaceutical sector.
DitchCarbon Score
How does Shenzhen Haibin Pharmaceutical Co. Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shenzhen Haibin Pharmaceutical Co. Ltd's score of 23 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shenzhen Haibin Pharmaceutical Co. Ltd's reported carbon emissions
Shenzhen Haibin Pharmaceutical Co. Ltd, headquartered in CN, currently does not have available carbon emissions data for recent years, as indicated by the absence of specific figures. Consequently, there are no reported emissions in terms of Scope 1, 2, or 3. In the context of climate commitments, the company has not outlined any specific reduction targets or initiatives, nor have they made any pledges related to climate action. This lack of publicly available information suggests that Shenzhen Haibin Pharmaceutical may still be in the early stages of developing a comprehensive climate strategy. As the pharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Shenzhen Haibin to establish clear emissions reduction goals and engage in climate initiatives to align with global standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shenzhen Haibin Pharmaceutical Co. Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
